| Year |
Citation |
Score |
| 2024 |
Higuchi F, Uzuka T, Matsuda H, Sumi T, Iwata K, Namatame T, Shin M, Akutsu H, Ueki K. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment. Brain Tumor Pathology. PMID 38294664 DOI: 10.1007/s10014-024-00477-w |
0.323 |
|
| 2020 |
Otani R, Mukasa A, Uzuka T, Higuchi F, Matsuda H, Tanaka S, Kim P, Ueki K. MPC-11 Comprehensive gene expression analysis of IDH-mutated astrocytomas with 19q-loss Neuro-Oncology Advances. 2: ii12-ii12. DOI: 10.1093/noajnl/vdaa143.053 |
0.332 |
|
| 2019 |
Nobusawa S, Nakata S, Yoshida Y, Yamazaki T, Ueki K, Amano K, Yamamoto J, Miyahara M, Sugai T, Nakazato Y, Hirato J, Yokoo H. Secondary INI1-deficient rhabdoid tumors of the central nervous system: analysis of four cases and literature review. Virchows Archiv : An International Journal of Pathology. PMID 31707588 DOI: 10.1007/S00428-019-02686-7 |
0.356 |
|
| 2019 |
Otani R, Uzuka T, Higuchi F, Matsuda H, Kim P, Ueki K. MPC-07 MECHANISMS OF BETTER PROGNOSIS IN IDH-MUTATED ASTROCYTOMA WITH 19Q-LOSS Neuro-Oncology Advances. 1: ii23-ii23. DOI: 10.1093/noajnl/vdz039.104 |
0.356 |
|
| 2019 |
Arita H, Matsushita Y, Ohno M, Miyake Y, Saito K, Tanaka S, Nakamura T, Tamura K, Higuchi F, Sandika E, Sabit H, Hattori Y, Yamaguchi S, Okita Y, Sakamoto D, ... ... Ueki K, et al. PATH-37. PROGNOSTIC ROLE OF TERT PROMOTER MUTATIONS IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA Neuro-Oncology. 21: vi151-vi151. DOI: 10.1093/neuonc/noz175.633 |
0.565 |
|
| 2018 |
Otani R, Uzuka T, Higuchi F, Matsuda H, Nomura M, Tanaka S, Mukasa A, Ichimura K, Kim P, Ueki K. IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis. Cancer Science. PMID 29752851 DOI: 10.1111/cas.13635 |
0.331 |
|
| 2017 |
Aihara K, Mukasa A, Nagae G, Nomura M, Yamamoto S, Ueda H, Tatsuno K, Shibahara J, Takahashi M, Momose T, Tanaka S, Takayanagi S, Yanagisawa S, Nejo T, Takahashi S, ... ... Ueki K, et al. Genetic and epigenetic stability of oligodendrogliomas at recurrence. Acta Neuropathologica Communications. 5: 18. PMID 28270234 DOI: 10.1186/s40478-017-0422-z |
0.336 |
|
| 2017 |
Fukushima S, Yamashita S, Kobayashi H, Takami H, Fukuoka K, Nakamura T, Yamasaki K, Matsushita Y, Nakamura H, Totoki Y, Kato M, Suzuki T, Mishima K, Yanagisawa T, Mukasa A, ... ... Ueki K, et al. Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas. Acta Neuropathologica. PMID 28078450 DOI: 10.1007/S00401-017-1673-2 |
0.462 |
|
| 2014 |
Ueki K, Aihara K, Mukasa A, Higuchi F, Matsuda H, Kim P. GENETIC AND HISTOLOGICAL STABILITY OF OLIGODENDROGLIAL TUMORS WITH 1P/19Q CO-DELETION EVEN AFTER CHEMOTHERAPY AND OR RADIATION THERAPY Neuro-Oncology. 16: iii51-iii51. DOI: 10.1093/NEUONC/NOU209.36 |
0.314 |
|
| 2011 |
Higuchi F, Matsuda H, Okada Y, Kim P, Ueki K. Metastatic brain sarcoma with gliomatous component. Brain Tumor Pathology. 28: 365-9. PMID 21833576 DOI: 10.1007/s10014-011-0055-z |
0.64 |
|
| 2011 |
Watanabe A, Ogiwara H, Ehata S, Mukasa A, Ishikawa S, Maeda D, Ueki K, Ino Y, Todo T, Yamada Y, Fukayama M, Saito N, Miyazono K, Aburatani H. Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 12384-9. PMID 21750150 DOI: 10.1073/pnas.0906930108 |
0.514 |
|
| 2010 |
Nagaishi M, Tanaka Y, Iwatate K, Yokoo H, Ueki K, Hyodo A, Nakazato Y. Polar spongioblastoma: A high-grade glioma that does not contain the IDH1 mutation or 1p/19q LOH. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 30: 547-52. PMID 20102524 DOI: 10.1111/J.1440-1789.2009.01087.X |
0.36 |
|
| 2007 |
Okada Y, Ohno C, Ueki K, Ogino M, Kawamoto S, Kim P. Comparison of numerical change of epidermal growth factor receptor gene among pre- and postradiation glioma, and gliosis, and its clinical use. Brain Tumor Pathology. 24: 15-8. PMID 18095139 DOI: 10.1007/s10014-007-0213-5 |
0.673 |
|
| 2007 |
Kawamoto S, Matsuda H, Ueki K, Okada Y, Kim P. Neuromuscular choristoma of the oculomotor nerve: case report. Neurosurgery. 60: E777-8; discussion E. PMID 17415185 DOI: 10.1227/01.NEU.0000255352.56453.8E |
0.595 |
|
| 2005 |
Okada Y, Ueki K. [Individualized therapy for glioma]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 63: 288-92. PMID 16201536 |
0.582 |
|
| 2005 |
Ueki K. Oligodendroglioma: impact of molecular biology on its definition, diagnosis and management. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 25: 247-53. PMID 16193843 |
0.336 |
|
| 2005 |
Kambe A, Kamitani H, Watanabe T, Oka A, Inagaki H, Ishii T, Ueki K. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report. Surgical Neurology. 63: 62-4; discussion 64-. PMID 15639530 DOI: 10.1016/j.surneu.2004.03.026 |
0.342 |
|
| 2004 |
Mukasa A, Ueki K, Ge X, Ishikawa S, Ide T, Fujimaki T, Nishikawa R, Asai A, Kirino T, Aburatani H. Selective expression of a subset of neuronal genes in oligodendroglioma with chromosome 1p loss. Brain Pathology (Zurich, Switzerland). 14: 34-42. PMID 14997935 DOI: 10.1111/J.1750-3639.2004.Tb00495.X |
0.324 |
|
| 2002 |
Mukasa A, Ueki K, Matsumoto S, Tsutsumi S, Nishikawa R, Fujimaki T, Asai A, Kirino T, Aburatani H. Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p. Oncogene. 21: 3961-8. PMID 12037678 DOI: 10.1038/sj.onc.1205495 |
0.365 |
|
| 2002 |
Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, et al. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 196-201. PMID 11801559 |
0.388 |
|
| 2000 |
Bauman GS, Ino Y, Ueki K, Zlatescu MC, Fisher BJ, Macdonald DR, Stitt L, Louis DN, Cairncross JG. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. International Journal of Radiation Oncology, Biology, Physics. 48: 825-30. PMID 11020580 DOI: 10.1016/S0360-3016(00)00703-3 |
0.654 |
|
| 2000 |
Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, Portier BP, Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN, Jenkins RB. A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics. 64: 44-50. PMID 10708517 DOI: 10.1006/Geno.1999.6101 |
0.675 |
|
| 2000 |
Pohl U, Smith JS, Tachibana I, Ueki K, Lee HK, Ramaswamy S, Wu Q, Mohrenweiser HW, Jenkins RB, Louis DN. EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins. Genomics. 63: 255-62. PMID 10673336 DOI: 10.1006/Geno.1999.6087 |
0.677 |
|
| 1999 |
Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas Cancer Research. 59: 5995-5998. PMID 10606247 |
0.307 |
|
| 1999 |
Kawahara N, Kume H, Ueki K, Mishima K, Sasaki T, Kirino T. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease Neurology. 53: 208-210. PMID 10408561 |
0.361 |
|
| 1998 |
Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. Journal of the National Cancer Institute. 90: 1473-9. PMID 9776413 DOI: 10.1093/Jnci/90.19.1473 |
0.679 |
|
| 1998 |
Burns KL, Ueki K, Jhung SL, Koh J, Louis DN. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas. Journal of Neuropathology and Experimental Neurology. 57: 122-30. PMID 9600204 DOI: 10.1097/00005072-199802000-00003 |
0.541 |
|
| 1997 |
Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN. ANOVA, a putative astrocytic RNA-binding protein gene that maps to chromosome 19q13.3. Neurogenetics. 1: 31-6. PMID 10735272 DOI: 10.1007/S100480050005 |
0.592 |
|
| 1997 |
Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN. Chromosomal localization to 19q13.3, partial genomic structure and 5' cDNA sequence of the human symplekin gene. Somatic Cell and Molecular Genetics. 23: 229-31. PMID 9330635 DOI: 10.1007/Bf02721375 |
0.552 |
|
| 1997 |
Ono Y, Tamiya T, Ichikawa T, Matsumoto K, Furuta T, Ohmoto T, Akiyama K, Seki S, Ueki K, Louis DN. Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression. Acta Neuropathologica. 94: 21-7. PMID 9224526 DOI: 10.1007/S004010050667 |
0.546 |
|
| 1997 |
Hayashi Y, Ueki K, Waha A, Wiestler OD, Louis DN, von Deimling A. Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme. Brain Pathology (Zurich, Switzerland). 7: 871-5. PMID 9217972 DOI: 10.1111/J.1750-3639.1997.Tb00890.X |
0.54 |
|
| 1997 |
Burns KL, Ueki K, Louis DN. MOLECULAR GENETIC AND IMMUNOHISTOCHEMICAL ANALYSIS OF THE p16-cdk4-pRb PATHWAY IN GLIOBLASTOMAS Journal of Neuropathology and Experimental Neurology. 56: 581. DOI: 10.1097/00005072-199705000-00053 |
0.432 |
|
| 1996 |
Rosenberg JE, Lisle DK, Burwick JA, Ueki K, von Deimling A, Mohrenweiser HW, Louis DN. Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene. 13: 2483-5. PMID 8957092 |
0.578 |
|
| 1996 |
Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. Journal of Neuropathology and Experimental Neurology. 55: 1026-31. PMID 8857999 DOI: 10.1097/00005072-199655100-00002 |
0.6 |
|
| 1996 |
Ono Y, Ueki K, Joseph JT, Louis DN. Homozygous deletions of the CDKN2/p16 gene in dural hemangiopericytomas. Acta Neuropathologica. 91: 221-5. PMID 8834533 DOI: 10.1007/S004010050419 |
0.679 |
|
| 1996 |
Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Cancer Gene Therapy. 3: 99-106. PMID 8729908 |
0.503 |
|
| 1996 |
Reeves SA, Ueki K, Sinha B, Difiglia M, Louis DN. Regional expression and subcellular localization of the tyrosine-specific phosphatase SH-PTP2 in the adult human nervous system. Neuroscience. 71: 1037-42. PMID 8684607 DOI: 10.1016/0306-4522(95)00491-2 |
0.446 |
|
| 1996 |
Chou D, Miyashita T, Mohrenweiser HW, Ueki K, Kastury K, Druck T, von Deimling A, Huebner K, Reed JC, Louis DN. The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas. Cancer Genetics and Cytogenetics. 88: 136-40. PMID 8640722 DOI: 10.1016/0165-4608(95)00341-X |
0.629 |
|
| 1996 |
Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Research. 56: 150-3. PMID 8548755 |
0.583 |
|
| 1996 |
Louis DN, Rosenberg JE, Ueki K, Lisle DK, Burwick JA. THE CHROMOSOME 19Q OLIOMA TUMOR SUPPRESSOR GENE Journal of Neuropathology and Experimental Neurology. 55: 606. DOI: 10.1097/00005072-199605000-00018 |
0.567 |
|
| 1995 |
Yong WH, Ueki K, Chou D, Reeves SA, von Deimling A, Gusella JF, Mohrenweiser HW, Buckler AJ, Louis DN. Cloning of a highly conserved human protein serine-threonine phosphatase gene from the glioma candidate region on chromosome 19q13.3. Genomics. 29: 533-6. PMID 8666404 DOI: 10.1006/Geno.1995.9972 |
0.696 |
|
| 1995 |
Raffel C, Ueki K, Harsh GR, Louis DN. The multiple tumor suppressor 1/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor. Neurosurgery. 36: 971-4; discussion 97. PMID 7791990 DOI: 10.1227/00006123-199505000-00013 |
0.565 |
|
| 1995 |
Yong WH, Chou D, Ueki K, Harsh GR, von Deimling A, Gusella JF, Mohrenweiser HW, Louis DN. Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112. Journal of Neuropathology and Experimental Neurology. 54: 622-6. PMID 7666049 DOI: 10.1097/00005072-199509000-00002 |
0.704 |
|
| 1994 |
Rubio MP, Correa KM, Ueki K, Mohrenweiser HW, Gusella JF, von Deimling A, Louis DN. The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC. Cancer Research. 54: 4760-3. PMID 8062276 |
0.579 |
|
| 1994 |
Ueki K, Richardson EP, Henson JW, Louis DN. In situ polymerase chain reaction demonstration of JC virus in progressive multifocal leukoencephalopathy, including an index case. Annals of Neurology. 36: 670-3. PMID 7944303 DOI: 10.1002/Ana.410360421 |
0.457 |
|
| 1994 |
Xu L, Sgroi D, Sterner CJ, Beauchamp RL, Pinney DM, Keel S, Ueki K, Rutter JL, Buckler AJ, Louis DN. Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. Cancer Research. 54: 5262-4. PMID 7923151 |
0.505 |
|
| 1994 |
Ueki K, Rubio MP, Ramesh V, Correa KM, Rutter JL, von Deimling A, Buckler AJ, Gusella JF, Louis DN. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Human Molecular Genetics. 3: 1841-5. PMID 7849711 DOI: 10.1093/Hmg/3.10.1841 |
0.634 |
|
| Show low-probability matches. |